Literature DB >> 20427283

Obligate ordered binding of human lactogenic cytokines.

Jeffery L Voorhees1, Charles L Brooks.   

Abstract

Class 1 cytokines bind two receptors to create an active heterotrimeric complex. It has been argued that ligand binding to their receptors is an ordered process, but a structural mechanism describing this process has not been determined. We have previously described an obligate ordered binding mechanism for the human prolactin/prolactin receptor heterotrimeric complex. In this work we expand this conceptual understanding of ordered binding to include three human lactogenic hormones: prolactin, growth hormone, and placental lactogen. We independently blocked either of the two receptor binding sites of each hormone and used surface plasmon resonance to measure human prolactin receptor binding kinetics and stoichiometries to the remaining binding surface. When site 1 of any of the three hormones was blocked, site 2 could not bind the receptor. But blocking site 2 did not affect receptor binding at site 1, indicating a requirement for receptor binding to site 1 before site 2 binding. In addition we noted variable responses to the presence of zinc in hormone-receptor interaction. Finally, we performed Förster resonance energy transfer (FRET) analyses where receptor binding at subsaturating stoichiometries induced changes in FRET signaling, indicative of binding-induced changes in hormone conformation, whereas at receptor:hormone ratios in excess of 2:1 no additional changes in FRET signaling were observed. These results strongly support a conformationally mediated obligate-ordered receptor binding for each of the three lactogenic hormones.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20427283      PMCID: PMC2888414          DOI: 10.1074/jbc.M109.084988

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis.

Authors:  B C Cunningham; J A Wells
Journal:  Science       Date:  1989-06-02       Impact factor: 47.728

2.  The reduction of protein disulfide bonds in the absence of denaturants.

Authors:  T A Bewley; C H Li
Journal:  Int J Protein Res       Date:  1969

3.  Mutational analysis and protein engineering of receptor-binding determinants in human placental lactogen.

Authors:  H B Lowman; B C Cunningham; J A Wells
Journal:  J Biol Chem       Date:  1991-06-15       Impact factor: 5.157

Review 4.  The structural basis for biological signaling, regulation, and specificity in the growth hormone-prolactin system of hormones and receptors.

Authors:  Anthony A Kossiakoff
Journal:  Adv Protein Chem       Date:  2004

5.  Studies on prolactin. Selective reduction of the disulfide bonds of the ovine hormone.

Authors:  B A Doneen; T A Bewley; C H Li
Journal:  Biochemistry       Date:  1979-10-30       Impact factor: 3.162

6.  Zinc mediation of the binding of human growth hormone to the human prolactin receptor.

Authors:  B C Cunningham; S Bass; G Fuh; J A Wells
Journal:  Science       Date:  1990-12-21       Impact factor: 47.728

7.  Differential effects of zinc on functionally distinct human growth hormone mutations.

Authors:  K M Duda; C L Brooks
Journal:  Protein Eng       Date:  2003-07

Review 8.  Variation among species in the endocrine control of mammary growth and function: the roles of prolactin, growth hormone, and placental lactogen.

Authors:  I A Forsyth
Journal:  J Dairy Sci       Date:  1986-03       Impact factor: 4.034

9.  Measurement of protein using bicinchoninic acid.

Authors:  P K Smith; R I Krohn; G T Hermanson; A K Mallia; F H Gartner; M D Provenzano; E K Fujimoto; N M Goeke; B J Olson; D C Klenk
Journal:  Anal Biochem       Date:  1985-10       Impact factor: 3.365

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  7 in total

1.  Zinc binding to human lactogenic hormones and the human prolactin receptor.

Authors:  Jeffrey L Voorhees; Geeta Vittal Rao; Timothy J Gordon; Charles L Brooks
Journal:  FEBS Lett       Date:  2011-04-15       Impact factor: 4.124

2.  Lactogens and estrogens in breast cancer chemoresistance.

Authors:  Gila Idelman; Eric M Jacobson; Traci R Tuttle; Nira Ben-Jonathan
Journal:  Expert Rev Endocrinol Metab       Date:  2011-05

3.  Two independent histidines, one in human prolactin and one in its receptor, are critical for pH-dependent receptor recognition and activation.

Authors:  Mandar V Kulkarni; M Cristina Tettamanzi; James W Murphy; Camille Keeler; David G Myszka; Naomi E Chayen; Elias J Lolis; Michael E Hodsdon
Journal:  J Biol Chem       Date:  2010-09-30       Impact factor: 5.157

Review 4.  Unexploited therapies in breast and prostate cancer: blockade of the prolactin receptor.

Authors:  Eric M Jacobson; Eric R Hugo; Traci R Tuttle; Ruben Papoian; Nira Ben-Jonathan
Journal:  Trends Endocrinol Metab       Date:  2010-09-16       Impact factor: 12.015

5.  Architecture of the two metal-binding sites in prolactin.

Authors:  Janus Vang; Yulia Pustovalova; Dmitry M Korzhnev; Oksana Gorbatyuk; Camille Keeler; Michael E Hodsdon; Jeffrey C Hoch
Journal:  Biophys J       Date:  2022-02-19       Impact factor: 3.699

Review 6.  Molecular mechanisms of prolactin and its receptor.

Authors:  Charles L Brooks
Journal:  Endocr Rev       Date:  2012-05-10       Impact factor: 19.871

7.  A common model for cytokine receptor activation: combined scissor-like rotation and self-rotation of receptor dimer induced by class I cytokine.

Authors:  Xiaodong Pang; Huan-Xiang Zhou
Journal:  PLoS Comput Biol       Date:  2012-03-08       Impact factor: 4.475

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.